title: [Second primary malignant neoplasms in patients treated radically for carcinoma of oral cavity, larynx and lungs].
abstract: About 1% of the patients with oral cavity, larynx, and lung cancer get second primary malignant neoplasms every year. For laryngeal cancer the percentage exceeds 10. Second primary tumors in oral cavity, larynx, and lung cancer patients are also tobacco-related neoplasms. Smoking cessation by patients with oral cavity, larynx, and lung cancer may have significant influence on the prognosis. Vitamin A (retinol) and its analogues are promising for human cancer prevention.
authors.affiliation: Pracownia Epidemiologii Centrum Onkologii, Instytut im. M. Skłodowskiej-Curie w Krakowie.
authors.forename: J
authors.initials: J
authors.lastname: Pawlega
authors.forename: M
authors.initials: M
authors.lastname: Geleta
authors.forename: T
authors.initials: T
authors.lastname: Dyba
authors.forename: J
authors.initials: J
authors.lastname: Rachtan
mesh_terms: D006801:Humans; D007822:Laryngeal Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D007830:Larynx / Q000187:drug effects / Q000473:pathology / Q000601:surgery*; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000601:surgery*; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D009055:Mouth / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D009062:Mouth Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery*; D011044:Poland / Q000453:epidemiology; D014801:Vitamin A / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D014801:Vitamin A
vernacular_title: Drugie pierwotne nowotwory złośliwe u chorych leczonych radykalnie z powodu raka jamy ustnej, krtani i płuca.